GGrantIndex
← Leaderboards

Ross Okimoto

University Of California, San Francisco

$3,105,765
Attributed
$3,402,279
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $962.5K · FY201825
$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,402,279 · 3

By mechanism

R37$1,922,391 · 1
K08$886,860 · 1
R01$593,028 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Mediating

Research focus

MediatingMolecularMalignant NeoplasmsGenetic TranscriptionSignal TransductionGeneticRegulationProtein DegradationTumorPatient-Focused OutcomesPathway InteractionsImproved OutcomeExperimental StudyNeoplasm MetastasisBindingInnovationOncogenicProtein ExpressionCessation Of LifeLaboratoriesEtv4 GenePre-ClinicalHyperactivityInsight

Grant awards (12)

The role of IL-6/STAT3 signaling in CIC-DUX4 fusion sarcoma metastasis and immunosuppression$593,028
R01 · FY2025 · CA
Therapeutic degradation of Capicua (CIC) fused oncoproteins in undifferentiated sarcomas$369,431
R37 · FY2025 · CA · contact PI
Therapeutic degradation of Capicua (CIC) fused oncoproteins in undifferentiated sarcomas$369,431
R37 · FY2024 · CA · contact PI
Therapeutic degradation of Capicua (CIC) fused oncoproteins in undifferentiated sarcomas$369,431
R37 · FY2023 · CA · contact PI
Negative MAPK-RAS-ERK pathway regulation to sustain CIC-DUX4 expression$75,236
R37 · FY2023 · CA · contact PI
Therapeutic degradation of Capicua (CIC) fused oncoproteins in undifferentiated sarcomas$369,431
R37 · FY2022 · CA · contact PI
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis$177,372
K08 · FY2022 · CA · contact PI
Therapeutic degradation of Capicua (CIC) fused oncoproteins in undifferentiated sarcomas$369,431
R37 · FY2021 · CA · contact PI
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis$177,372
K08 · FY2021 · CA · contact PI
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis$177,372
K08 · FY2020 · CA · contact PI
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis$177,372
K08 · FY2019 · CA · contact PI
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis$177,372
K08 · FY2018 · CA · contact PI